Explore the latest advances in topoisomerase I inhibitors for cancer treatment, including novel compounds like DIA-001 and their mechanisms of action.
Explore how covalent topoisomerase II poisons weaponize essential DNA enzymes to create powerful cancer therapies and the scientific breakthroughs driving this field.